Condition (MeSH)
Ichthyosis Bullosa of Siemens
ClinicalTrials.gov lists 23 trials for Ichthyosis Bullosa of Siemens or a narrower condition beneath it. Oy Karl Fazer Ab has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
23 of the 23 trials are tagged with Ichthyosis Bullosa of Siemens itself; the rest are tagged with a narrower condition beneath it.
When did Ichthyosis Bullosa of Siemens trials start? (17)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 2
- Phase 3
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 2 |
| 2024 | 2 |
| 2023 | 1 |
| 2022 | 1 |
| 2018 | 1 |
| 2017 | 2 |
| 2016 | 1 |
| 2015 | 1 |
| 2014 | 1 |
Showing 10 of 17 earlier years.
No forecast is made for this condition: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Ichthyosis Bullosa of Siemens trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Phase 2 | 3 |
| Phase 3 | 3 |
| Not applicable | 10 |
| Observational | 6 |
How many Ichthyosis Bullosa of Siemens trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 2 |
| Completed | 17 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Ichthyosis Bullosa of Siemens trials? (6)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Oy Karl Fazer Ab | 2 |
| Abbott | 1 |
| Adamas Biotech S.r.l. | 1 |
| Biocodex | 1 |
| Click Therapeutics, Inc. | 1 |
Showing 5 of 6 sponsors.
Which drugs are being tested for Ichthyosis Bullosa of Siemens? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| CURCUMIN | 1 |
| ROSE-010 | 1 |
| DDP225 | 1 |
Interventions as named in the registry (7)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Saccharomyces Boulardii 250 MG | 1 |
| Rezular 15mg | 1 |
| Chang Ji'an capsule | 1 |
| Rimegepant/BHV3000 | 1 |
| Rezular | 1 |
Showing 5 of 7 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Prevalence (6)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Superficial epidermolytic ichthyosis | Point prevalence | <1 / 1 000 000 | Worldwide | Not stated | Unspecified |
| Superficial epidermolytic ichthyosis | Point prevalence | <1 / 1 000 000 | Worldwide | Not stated | Exact |
| Superficial epidermolytic ichthyosis | Cases families | Worldwide | Not stated | Exact | |
| Superficial epidermolytic ichthyosis | Point prevalence | <1 / 1 000 000 | Worldwide | Not stated | Exact |
| Superficial epidermolytic ichthyosis | Cases families | Worldwide | Not stated | Unspecified |
Showing 5 of 6 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Superficial epidermolytic ichthyosis | 455 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Superficial epidermolytic ichthyosis | 455 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, publications, and sub-conditions in mesh.